Exploration Capital, LLC, 10% Owner at Fresh Tracks Therapeutics, Inc. (FRTX), bought 19,996 shares at $0.98 ($20K) on 2024-01-12, disclosed to the SEC on 2024-01-17.
Open-market purchase of $20k FRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.98 | 10,958 | $11K | 54.5% |
| 2 | $0.99 | 9,038 | $9K | 45.5% |
| Total | $0.98 avg | 19,996 | $20K | 100% |
| Filing → |
| FRTX | BUY | 2024-05-23 | $21K | — | Filing → |
| FRTX | BUY | 2024-05-20 | $136K | — | Filing → |
| FRTX | BUY | 2024-05-08 | $285 | — | Filing → |